ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,460.48
      -0.41%
      US Tech 100
      19,181.60
      -0.43%
      Dow Jones
      39,118.86
      -0.12%
      Brent Oil
      84.85
      0.00%
      Bitcoin
      61,514.37
      1.02%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Inovio Pharmaceuticals Inc New (INO)

      7. Inovio Pharmaceuticals Inc New (INO) News

      INO

      Inovio Pharmaceuticals (INO)

      Inovio Pharmaceuticals Inc New
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:INO
      DateTimeSourceHeadlineSymbolCompany
      11/09/20178:00AMGlobeNewswire Inc.Inovio Pharmaceuticals to Participate In Upcoming Investment ConferencesNASDAQ:INOInovio Pharmaceuticals Inc New
      11/08/20174:05PMGlobeNewswire Inc.Inovio Pharmaceuticals Reports 2017 Third Quarter Financial ResultsNASDAQ:INOInovio Pharmaceuticals Inc New
      11/08/20173:58PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INOInovio Pharmaceuticals Inc New
      11/02/20176:07AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INOInovio Pharmaceuticals Inc New
      11/01/20179:18AMGlobeNewswire Inc.Inovio Pharmaceuticals Initiates Immuno-Oncology Clinical Study for Glioblastoma in Combination with Regeneron’s PD-1 Inhi...NASDAQ:INOInovio Pharmaceuticals Inc New
      10/26/20178:00AMGlobeNewswire Inc.Inovio Pharmaceuticals to Report Third Quarter 2017 Financial Results on November 8, 2017NASDAQ:INOInovio Pharmaceuticals Inc New
      10/24/20178:00AMGlobeNewswire Inc.Inovio and U.S. Army Co-developing Novel Vaccine That Completely Prevents Lethal Lassa Fever Infection in Pre-Clinical Study...NASDAQ:INOInovio Pharmaceuticals Inc New
      10/16/20177:00AMGlobeNewswire Inc.Inovio Pharmaceuticals Begins Phase 1b/2 Cancer Efficacy Trial Combining Its T-cell Immunotherapy with a PD-L1 Checkpoint Inh...NASDAQ:INOInovio Pharmaceuticals Inc New
      10/05/20177:00AMGlobeNewswire Inc.Inovio’s Positive Zika Vaccine Clinical Study Data Published in New England Journal of MedicineNASDAQ:INOInovio Pharmaceuticals Inc New
      09/21/20178:00AMGlobeNewswire Inc.Inovio dMAb™ Constructs Shrink Prostate Tumors and Protect Against Lethal Antibiotic-Resistant Bacterial Infection In Prec...NASDAQ:INOInovio Pharmaceuticals Inc New
      09/18/20178:00AMGlobeNewswire Inc.Inovio and Partners Initiate Phase 1/2a Clinical Trial To Further Advance Its Vaccine Against Deadly MERS InfectionNASDAQ:INOInovio Pharmaceuticals Inc New
      09/11/20178:00AMGlobeNewswire Inc.Inovio’s Cancer Immunotherapy (INO-5150) Slowed PSA Rise and Significantly Increased PSA Doubling Times In Patients with R...NASDAQ:INOInovio Pharmaceuticals Inc New
      08/23/20178:00AMGlobeNewswire Inc.Inovio Pharmaceuticals to Participate in Upcoming Investment ConferencesNASDAQ:INOInovio Pharmaceuticals Inc New
      08/08/20174:14PMGlobeNewswire Inc.Inovio Pharmaceuticals Reports 2017 Second Quarter Financial ResultsNASDAQ:INOInovio Pharmaceuticals Inc New
      08/08/20173:50PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INOInovio Pharmaceuticals Inc New
      08/01/20172:27PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INOInovio Pharmaceuticals Inc New
      07/26/20178:00AMGlobeNewswire Inc.Inovio Pharmaceuticals to Report Second Quarter 2017 Financial Results on August 8, 2017NASDAQ:INOInovio Pharmaceuticals Inc New
      07/20/20175:24PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INOInovio Pharmaceuticals Inc New
      07/20/20174:37PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:INOInovio Pharmaceuticals Inc New
      07/19/201710:10PMGlobeNewswire Inc.Inovio Announces Pricing of Public Offering of Common StockNASDAQ:INOInovio Pharmaceuticals Inc New
      07/18/20174:15PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INOInovio Pharmaceuticals Inc New
      07/18/20174:05PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:INOInovio Pharmaceuticals Inc New
      07/18/20174:01PMGlobeNewswire Inc.Inovio Announces Proposed Public Offering of Common StockNASDAQ:INOInovio Pharmaceuticals Inc New
      07/14/20179:11AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INOInovio Pharmaceuticals Inc New
      07/06/20178:00AMGlobeNewswire Inc.Inovio’s DNA-based Monoclonal Antibody Platform Achieves Further Proof-of-Principle ValidationNASDAQ:INOInovio Pharmaceuticals Inc New
      06/28/20178:00AMGlobeNewswire Inc.Inovio Announces Leadership AppointmentsNASDAQ:INOInovio Pharmaceuticals Inc New
      06/19/20178:00AMGlobeNewswire Inc.Inovio Pharmaceuticals to Participate on Panel at 2017 BIO International ConventionNASDAQ:INOInovio Pharmaceuticals Inc New
      06/15/20178:00AMGlobeNewswire Inc.Inovio Fully Enrolls 160 Subjects in Puerto Rico for Second Zika Vaccine Phase 1 Trial; Continues Leadership to Advance an Ef...NASDAQ:INOInovio Pharmaceuticals Inc New
      06/12/20179:57AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INOInovio Pharmaceuticals Inc New
      06/08/20176:00AMGlobeNewswire Inc.Inovio Begins Phase 3 Clinical Trial of VGX-3100 for the Treatment of HPV-Related Cervical Pre-Cancer NASDAQ:INOInovio Pharmaceuticals Inc New
       Showing the most relevant articles for your search:NASDAQ:INO

      Your Recent History

      BIT
      F18170
      Vontobel Financial Produ...
      Delayed Upgrade Clock